Lower airway inflammation in infants and young children with cystic fibrosis
- PMID: 9351622
- DOI: 10.1164/ajrccm.156.4.96-11058
Lower airway inflammation in infants and young children with cystic fibrosis
Abstract
Airway inflammation is an important component of cystic fibrosis (CF) lung disease. To determine whether this begins early in the illness, before the onset of infection, we examined bronchoalveolar lavage (BAL) fluid from 46 newly diagnosed infants with CF under the age of 6 mo identified by a neonatal screening program. These infants were divided into three groups: 10 had not experienced respiratory symptoms or received antibiotics and pathogens were absent in their BAL fluid; 18 had clear evidence of lower respiratory viral or bacterial (> or = 10(5) CFU/ml) infection; and the remaining 18 had either respiratory symptoms, taken antibiotics, or had < 10(5) CFU/ml of respiratory pathogens. Their BAL cytology, interleukin-8, and elastolytic activity were compared with those from 13 control subjects. In a longitudinal study to assess if inflammation develops or persists in the absence of infection, the results of 56 paired annual BAL specimens from 44 CF infants were grouped according to whether they showed absence, development, clearance, or persistence of infection. In newly diagnosed infants with CF, those without infection had BAL profiles comparable with control subjects while those with a lower respiratory infection had evidence of airway inflammation. In older children, the development and persistence of infection was accompanied by increased inflammatory markers, whereas these were decreased in the absence, or with the clearance, of infection. We conclude that airway inflammation follows respiratory infection and, in young children, improves when pathogens are eradicated from the airways.
Similar articles
-
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.Pediatr Pulmonol. 2005 Dec;40(6):500-10. doi: 10.1002/ppul.20294. Pediatr Pulmonol. 2005. PMID: 16208679
-
Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.Am J Respir Crit Care Med. 2002 Apr 1;165(7):904-10. doi: 10.1164/ajrccm.165.7.2010139. Am J Respir Crit Care Med. 2002. PMID: 11934712
-
Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.Pediatr Pulmonol. 2009 Apr;44(4):402-9. doi: 10.1002/ppul.21028. Pediatr Pulmonol. 2009. PMID: 19283840
-
Disease surveillance using bronchoalveolar lavage.Paediatr Respir Rev. 2008 Sep;9(3):151-9. doi: 10.1016/j.prrv.2008.01.002. Epub 2008 Jul 30. Paediatr Respir Rev. 2008. PMID: 18694706 Review.
-
[Early bronchial inflammation in cystic fibrosis].J Soc Biol. 2002;196(1):29-35. J Soc Biol. 2002. PMID: 12134630 Review. French.
Cited by
-
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences.Biomed Res Int. 2016;2016:5258727. doi: 10.1155/2016/5258727. Epub 2016 Jun 1. Biomed Res Int. 2016. PMID: 27340661 Free PMC article. Review.
-
Lung immunoglobulin A immunity dysregulation in cystic fibrosis.EBioMedicine. 2020 Oct;60:102974. doi: 10.1016/j.ebiom.2020.102974. Epub 2020 Sep 11. EBioMedicine. 2020. PMID: 32927272 Free PMC article.
-
Antibiotic and anti-inflammatory therapies for cystic fibrosis.Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a009779. doi: 10.1101/cshperspect.a009779. Cold Spring Harb Perspect Med. 2013. PMID: 23880054 Free PMC article. Review.
-
RPTOR, a novel _target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF.RNA Biol. 2016 Sep;13(9):837-47. doi: 10.1080/15476286.2016.1197484. Epub 2016 Jun 10. RNA Biol. 2016. PMID: 27284727 Free PMC article.
-
The changing microbial epidemiology in cystic fibrosis.Clin Microbiol Rev. 2010 Apr;23(2):299-323. doi: 10.1128/CMR.00068-09. Clin Microbiol Rev. 2010. PMID: 20375354 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical